Introduction
Human
Veterinary
Environmental
Industrial
Agricultural
Introduction
Medical
Veterinary
Environmental
Industrial
Agricultural
Introduction
Susceptibility
MIC Database
Procedures
Histopathology
Introduction
Abbreviations
Links
CME
Conference
Highlights
Bibliography
Glossary
Good Books
Events
Calendar
Introduction
Our Mission
Editorial Board
Editorial Staff
Supporters
Contributors
Legal Stuff
Privacy Policy
Kudos
This page updated:
1/7/2007 12:48:00 PM
DoctorFungus - All Rights Reserved
© 2007 Copyright
& Privacy Policy
Site built and designed for doctorfungus by Webillustrated
|
 |
 |
 |
|
You are here:
The Fungi > Descriptions >
|
Aspergillus niger
Van Tieghem, 1867
|
Colonies on potato dextrose agar at 25°C are initially white, quickly becoming black with conidial production. Reverse is pale yellow and growth may produce radial fissures in the agar.
Hyphae are septate and hyaline. Conidial heads are radiate initially, splitting into columns at maturity. The species is biseriate (vesicles produces sterile cells known as metulae that support the conidiogenous phialides). Conidiophores are long (400-3000 µm), smooth, and hyaline, becoming darker at the apex and terminating in a globose vesicle (30-75 µm in diameter). Metulae and phialides cover the entire vesicle. Conidia are brown to black, very rough, globose, and measure 4-5 µm in diameter [2202], [531].
Organism is a common secondary invader following bacterial otitis [2153]. May also cause pulmonary disease in immunocompromised patients and the production of oxalate crystals in clinical specimens [1611].
| AMB |
CAS |
ITRA |
VORI |
POSA |
KETO |
TERB |
5FC |
MICA |
ANID |
| 0.125 µg/ml=2 |
0.03 µg/ml=16 |
0.03 µg/ml=1 |
0.06 µg/ml=1 |
0.03 µg/ml=1 |
2.0 µg/ml=1 |
0.015 µg/ml=1 |
8 µg/ml=2 |
≤0.03 µg/ml=1 |
≤0.03 µg/ml=1 |
| 0.25 µg/ml=8 |
0.125 µg/ml=31 |
0.125 µg/ml=3 |
0.125 µg/ml=3 |
0.06 µg/ml=3 |
4.0 µg/ml=5 |
0.03 µg/ml=4 |
16 µg/ml=1 |
|
|
| 0.5 µg/ml=47 |
0.25 µg/ml=8 |
0.25 µg/ml=6 |
0.25 µg/ml=4 |
0.125 µg/ml=6 |
8.0 µg/ml=4 |
0.06 µg/ml=1 |
64 µg/ml=2 |
|
|
| 1.0 µg/ml=35 |
0.5 µg/ml=1 |
0.5 µg/ml=23 |
0.5 µg/ml=38 |
0.25 µg/ml=6 |
16 µg/ml=1 |
0.125 µg/ml=3 |
>64 µg/ml=3 |
|
|
| 16 µg/ml=1 |
|
1.0 µg/ml=29 |
1.0 µg/ml=31 |
|
|
|
|
|
|
| |
|
2.0 µg/ml=5
| 2.0 µg/ml=4
| |
|
|
|
|
|
| |
|
4.0 µg/ml=5 |
|
|
|
|
|
|
|
| |
|
8.0 µg/ml=2 |
|
|
|
|
|
|
|
| Drug/N |
AMB/93 |
CAS/56 |
ITRA/74 |
VORI/81 |
POSA/16 |
| MIC Range |
0.125-16 |
0.03-0.5 |
0.03-1.0 |
0.125-2.0 |
0.06-0.25 |
| MIC50 |
0.5 |
0.125 |
0.5 |
0.5 |
0.125 |
| MIC90 |
1.0 |
0.25 |
1.0 |
1.0 |
0.25 |
* Fungus Testing Laboratory unpublished data (NCCLS M38-A)
PubMed
GenBank
|
|
|

References
531. de Hoog, G. S., J. Guarro, J. Gene, and M. J. Figueras. 2000. Atlas of Clinical Fungi, 2nd ed, vol. 1. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands.
1611. Nakagawa, Y., K. Shimazu, M. Ebihara, and K. Nakagawa. 1999. Aspergillus niger pneumonia with fatal pulmonary oxalosis. J Infect Chemother. 5:97-100.
2153. Steinbach, W. J., and D. A. Stevens. 2003. Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis. Clin Infect Dis. 37:S157-S187.
2202. Sutton, D. A., A. W. Fothergill, and M. G. Rinaldi (ed.). 1998. Guide to Clinically Significant Fungi, 1st ed. Williams & Wilkins, Baltimore.
|